Close Menu

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Monday that its third quarter revenues fell 3 percent, with Chairman and CEO Robert Friel blaming "challenging market conditions" for the drop.

For the three months ended Oct. 2, the company said revenues fell to $548.1 million from $563.4 million in Q3 2015, widely missing Wall Street analysts' average estimate of $572.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.